Clinical Trials Browser

Solid Tumors Refractory to Standard Therapy

NCT06222593 2025-02-17

Study to Evaluate the Safety and Efficacy of Bicalutamide in Combination with Sunitinib in Patients with TKIs-resistant RCC

Phase 1/2 Recruiting

28 enrolled

Genitourinary

Carcinoma, Renal Cell

NCT03277924 2024-08-13

ImmunoSarc

Phase 1/2 Completed

197 enrolled

Sarcoma

Chondrosarcoma, Extraskeletal Myxoid, Bone Neoplasms, Chondrosarcoma, Hemangioendothelioma, Hemangiosarcoma, Leiomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma, Sarcoma, Synovial, Sarcoma, Clear Cell, Sarcoma, Alveolar Soft Part, Hemangioendothelioma, Epithelioid, Histiocytoma, Malignant Fibrous, Solitary Fibrous Tumors

Clinical Trials

COPS-01

Study to Evaluate the Safety and Efficacy of Bicalutamide in Combination with Sunitinib in Patients with TKIs-resistant RCC

ImmunoSarc

EXTENT

Clinical Study of SU 11248 (Sutent) Combined With Standard Chemotherapy in Patients With FLT3 Mutated AML Over 60 Years

Sunitinib, Cyclophosphamide, and Methotrexate in Treating Patients With Metastatic Breast Cancer

Sutent and Radiation as Treatment for Limited Extent Metastatic Cancer

SU011248 in Combination With Irinotecan and Cetuximab as a Second Line Regimen for Stage IV Colorectal Cancer

Taxotere/Prednisone Plus Sunitinib in Chemotherapy-Naïve, Hormone Refractory Prostate Cancer Patients

QUASAR

Study of Pegylated Alfa Interferon, Sunitinib and Tarceva in Patients With Metastatic RCC

Palliative Radiofrequency Ablation in Metastatic Renal Cell Carcinoma Patients

SUNXRT

A Phase I/II Study of Sunitinib and Dacarbazine

rcc

Temodar and Sutent as Therapy for Melanoma

Activity Study of Sunitinib In Metastatic Pretreated Urothelial Cancer